Simon Low

Pharmacologic Profile of the Adnectin BMS-962476, a Small Protein Biologic Alternative to PCSK9 Antibodies for Low-Density Lipoprotein Lowering

Tracy Mitchell, Doree Sitkoff, Fred Lo et al. · Journal of Pharmacology and Experimental Therapeutics · 2014 · 132 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Research Article: Selectivity‐determining Residues in Plk1

Michael Kothe, Darcy Kohls, Simon Low et al. · Chemical Biology & Drug Design · 2007 · 128 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +13

Structure of the Catalytic Domain of Human Polo-like Kinase 1^,

Michael Kothe, Darcy Kohls, Simon Low et al. · Biochemistry · 2007 · 123 citations

Life Sciences, Molecular Biology, Oncology +13

Structural Determinants for Inhibitor Specificity and Selectivity in PDE2A Using the Wheat Germ in Vitro Translation System

André Iffland, Darcy Kohls, Simon Low et al. · Biochemistry · 2005 · 62 citations

Life Sciences, Biochemistry, Pharmacology +13

Developing Adnectins That Target SRC Co-Activator Binding to PXR: A Structural Approach toward Understanding Promiscuity of PXR

Javed Khan, Daniel M. Camac, Simon Low et al. · Journal of Molecular Biology · 2015 · 25 citations · Full text

Pharmacy, Molecular Biology, Pharmacology +16